If this box remains here for more than 30 seconds, click this link to try again.
Products & Services ╗
Best Practice Database
Market Research, Analytics and Forecasting ╗ Analytics
Download FREE Excerpt
23 Info Graphics
13 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The last decade has seen an explosion in the availability of data that can deliver valuable insights for the pharmaceutical sector– from Electronic Medical Records and clinical trial data to medical claims and patient behavior data. All these information types are part of the large and complex data sets that make up what’s called Big Data.
The inherent costs and challenges that come with harnessing large sets of information in varied formats have caused the pharmaceutical sector to embrace Big Data analytics slower than other industries. As organizations move to develop Big Data capabilities they are wrestling with questions such as what is the appropriate staffing and budget levels, what data capabilities do we need and should analytics be centralized or decentralized?
Best Practices, LLC undertook this study to probe these issues as well as current trends and best practices in utilizing Big Data in the pharmaceutical sector. The study offers key benchmarks around staffing and budget levels, the dissemination of data analysis, Big Data capabilities and analysis of centralized vs. decentralized structural approaches for analytics.
Pharmaceutical; Health Care; Biotech; Chemical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Biopharmaceutical; Clinical Research; Laboratories
Merck; Merck Serono; Novartis; Boehringer Ingelheim; Genentech; Teva Pharmaceutical Industries Ltd; Pfizer; Baxter Healthcare; GlaxoSmithKline ; Bayer; Gilead Sciences; Janssen; Lundbeck; Sanofi; Esteve; Daiichi Sankyo; Purdue Pharma; AstraZeneca
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.